Primary clinical study on treatment with velcade for multiple myeloma
- Cite this article as:
- Li, C., Wu, D., Sun, A. et al. Chin.- Ger. J. Clin. Oncol. (2007) 6: 579. doi:10.1007/s10330-007-0104-6
- 22 Views
To explore the outcome and side-effects in patients with multiple myeloma treated with velcade and combined chemotherapy.
6 patients with multiple myeloma were treated with the combination of velcade and dexamethasone or DVD (V-DVD regimen) chemotherapy.
6 patients responded to treatment. 4 patients achieved complete remission (CR), 1 achieved partial remission (PR) and 1 achieved micro responded (MR). Major toxicities consisted of peripheral neuropathy, thrombocytopenia and hepatic impairment.
Velcade combined chemotherapy is an effective and safety treatment for patients with multiple myeloma.